Bakheet Elsadek

2.1k total citations · 1 hit paper
37 papers, 1.7k citations indexed

About

Bakheet Elsadek is a scholar working on Molecular Biology, Biomaterials and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Bakheet Elsadek has authored 37 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 6 papers in Biomaterials and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Bakheet Elsadek's work include Nanoparticle-Based Drug Delivery (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Bakheet Elsadek is often cited by papers focused on Nanoparticle-Based Drug Delivery (5 papers), Cancer, Lipids, and Metabolism (4 papers) and Monoclonal and Polyclonal Antibodies Research (3 papers). Bakheet Elsadek collaborates with scholars based in Egypt, Saudi Arabia and Germany. Bakheet Elsadek's co-authors include Felix Kratz, Ahmed M. Mansour, Mostafa Abdelrahman, Ahmed S. Aboraia, Montaser Sh. A. Shaykoon, Amira M. Abo‐Youssef, Salama A. Salama, Basim Anwar Shehata Messiha, Amr D. Mariee and Ahmed S. Doghish and has published in prestigious journals such as Scientific Reports, Journal of Controlled Release and Life Sciences.

In The Last Decade

Bakheet Elsadek

35 papers receiving 1.7k citations

Hit Papers

Impact of albumin on drug delivery — New applications on ... 2011 2026 2016 2021 2011 200 400 600

Peers

Bakheet Elsadek
Bakheet Elsadek
Citations per year, relative to Bakheet Elsadek Bakheet Elsadek (= 1×) peers Rosa Maria Iacobazzi

Countries citing papers authored by Bakheet Elsadek

Since Specialization
Citations

This map shows the geographic impact of Bakheet Elsadek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bakheet Elsadek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bakheet Elsadek more than expected).

Fields of papers citing papers by Bakheet Elsadek

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bakheet Elsadek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bakheet Elsadek. The network helps show where Bakheet Elsadek may publish in the future.

Co-authorship network of co-authors of Bakheet Elsadek

This figure shows the co-authorship network connecting the top 25 collaborators of Bakheet Elsadek. A scholar is included among the top collaborators of Bakheet Elsadek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bakheet Elsadek. Bakheet Elsadek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Orabi, Mohamed A. A., Mohamed E. Abouelela, Mohamed Salaheldin A. Abdelkader, et al.. (2024). Ceiba pentandra ethyl acetate extract improves doxorubicin antitumor outcomes against chemically induced liver cancer in rat model: a study supported by UHPLC-Q-TOF-MS/MS identification of the bioactive phytomolecules. Frontiers in Pharmacology. 15. 1337910–1337910. 7 indexed citations
3.
Mansour, Ahmed M., et al.. (2023). Estrogen Attenuates Diethylnitrosamine-Induced Hepatocellular Carcinoma in Female Rats <i>via</i> Modulation of Estrogen Receptor/FASN/CD36/IL-6 Axis. Biological and Pharmaceutical Bulletin. 46(11). 1558–1568. 1 indexed citations
4.
Mansour, Ahmed M., et al.. (2023). Estrogen/estrogen receptor activation protects against DEN-induced liver fibrosis in female rats via modulating TLR-4/NF-kβ signaling. European Journal of Pharmacology. 960. 176165–176165. 8 indexed citations
5.
Elsayed, Mahmoud M. A., Moustafa O. Aboelez, Bakheet Elsadek, et al.. (2022). Tolmetin Sodium Fast Dissolving Tablets for Rheumatoid Arthritis Treatment: Preparation and Optimization Using Box-Behnken Design and Response Surface Methodology. Pharmaceutics. 14(4). 880–880. 33 indexed citations
6.
Abuhamdah, Sawsan, et al.. (2022). Circulating Ubiquitin Carboxyl Terminal Hydrolase L1 and Neuroglobin Levels in Traumatic Spinal Cord Injuries: Relation to Severity and Outcomes. International Journal of General Medicine. Volume 15. 5795–5805.
7.
Hassan, Mohammed H., et al.. (2022). Expression Patterns of Macrophage Migration Inhibitory Factor and Its Gene Variants (MIF-173 G˃C) in Verruca Vulgaris. Clinical Cosmetic and Investigational Dermatology. Volume 15. 1073–1085. 1 indexed citations
8.
Elsadek, Bakheet & Mohammed H. Hassan. (2021). Screening for new peptide substrates for the development of albumin binding anticancer pro-drugs that are cleaved by prostate-specific antigen (PSA) to improve the anti tumor efficacy. Biochemistry and Biophysics Reports. 26. 100966–100966. 3 indexed citations
10.
Hegazy, Maghawry, et al.. (2020). Pioglitazone ameliorates high fat diet-induced hypertension and induces catechol o-methyl transferase expression in rats. European Journal of Pharmacology. 885. 173383–173383. 4 indexed citations
11.
Elsakka, Elsayed G.E., et al.. (2020). Androgen/androgen receptor affects gentamicin-induced nephrotoxicity through regulation of megalin expression. Life Sciences. 251. 117628–117628. 27 indexed citations
12.
Elsayed, Mahmoud M. A., Eman Alaaeldin, Hatem A. Sarhan, et al.. (2019). <p>Design And Characterisation Of Novel Sorafenib-Loaded Carbon Nanotubes With Distinct Tumour-Suppressive Activity In Hepatocellular Carcinoma</p>. International Journal of Nanomedicine. Volume 14. 8445–8467. 50 indexed citations
13.
Mohamed, Mamdouh F. A., Bahaa G. M. Youssif, Montaser Sh. A. Shaykoon, et al.. (2019). Utilization of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidinone as a cap moiety in design of novel histone deacetylase inhibitors. Bioorganic Chemistry. 91. 103127–103127. 46 indexed citations
14.
Abouelela, Mohamed E., Mohamed A. A. Orabi, Mohamed Salaheldin A. Abdelkader, et al.. (2019). Ethyl acetate extract of Ceiba pentandra (L.) Gaertn. reduces methotrexate-induced renal damage in rats via antioxidant, anti-inflammatory, and antiapoptotic actions. Journal of Traditional and Complementary Medicine. 10(5). 478–486. 24 indexed citations
15.
Elsadek, Bakheet, et al.. (2017). Development and optimization of a novel drug free nanolipid vesicular system for treatment of osteoarthritis. Drug Development and Industrial Pharmacy. 44(5). 767–777. 5 indexed citations
16.
Mohamed, Mamdouh F. A., Montaser Sh. A. Shaykoon, Mostafa Abdelrahman, et al.. (2017). Design, synthesis, docking studies and biological evaluation of novel chalcone derivatives as potential histone deacetylase inhibitors. Bioorganic Chemistry. 72. 32–41. 55 indexed citations
17.
Elsadek, Bakheet, Ahmed M. Mansour, Tahia H. Saleem, André Warnecke, & Felix Kratz. (2016). The antitumor activity of a lactosaminated albumin conjugate of doxorubicin in a chemically induced hepatocellular carcinoma rat model compared to sorafenib. Digestive and Liver Disease. 49(2). 213–222. 28 indexed citations
18.
Salama, Ragaa H. M., et al.. (2011). Implication of Umbilical Cord in Preeclampsia. Medical Principles and Practice. 20(2). 124–128. 10 indexed citations
19.
Elsadek, Bakheet, Ralph Graeser, N. Esser, et al.. (2010). Development of a novel prodrug of paclitaxel that is cleaved by prostate-specific antigen: An in vitro and in vivo evaluation study. European Journal of Cancer. 46(18). 3434–3444. 39 indexed citations
20.
Elsadek, Bakheet, Ralph Graeser, N. Esser, et al.. (2010). In vivo evaluation of a novel albumin-binding prodrug of doxorubicin in an orthotopic mouse model of prostate cancer (LNCaP). Prostate Cancer and Prostatic Diseases. 14(1). 14–21. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026